1. A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma. Issue 11 (24th May 2020) Authors: Lewis, Elizabeth C.; Kraveka, Jacqueline M.; Ferguson, William; Eslin, Don; Brown, Valerie I.; Bergendahl, Genevieve; Roberts, William; Wada, Randal K.; Oesterheld, Javier; Mitchell, Deanna; Foley, Jessica; Zage, Peter; Rawwas, Jawhar; Rich, Maria; Lorenzi, Elizabeth; Broglio, Kristine; Berry, Do... Journal: International journal of cancer Issue: Volume 147:Issue 11(2020) Page Start: 3152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma. (21st April 2017) Authors: Maser, Tyler; Rich, Maria; Hayes, David; Zhao, Ping; Nagulapally, Abhinav B.; Bond, Jeffrey; Saulnier Sholler, Giselle Journal: Cancer medicine Issue: Volume 6:Number 6(2017:Jun.) Page Start: 1341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗